Johnson & Johnson (JNJ) Operating Income (2009 - 2026)
Johnson & Johnson's Operating Income came in at $6.18 billion for Q3 2026, down 12.1% from $7.03 billion a year earlier and down 13.4% from the prior quarter.
Johnson & Johnson (JNJ) Operating Income (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 27, 2026, Johnson & Johnson reported Operating Income of $25.19 billion, up 7.4% year-over-year; for FY2025, it came in at $25.37 billion, up 20.7% from FY2024.
- Operating Income carries a four-year compound annual growth rate of 6.6% (FY2021 to FY2025).
- Going back by year, Operating Income was $21.02 billion in FY2024 (-2.3%), $21.52 billion in FY2023 (+3.8%), $20.74 billion in FY2022 and $19.67 billion in FY2021.
- The five-year range for quarterly Operating Income is $3.6 billion (Q4 2024) to $7.14 billion (Q2 2026).
- Year-over-year, Operating Income increased in six of the last eight quarters, with growth averaging 10.4%.
- The fastest year-over-year change in Operating Income over five years came in Q4 2025 (growth of 53.0%), and the weakest in Q4 2023 (a decline of 38.1%).
- Business Quant data shows JNJ's Operating Income at $7.14 billion (Q2 2026), $6.36 billion (Q1 2026) and $5.51 billion (Q4 2025) in the three quarters before Q3 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 8.41 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 6.18 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 6.27 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 5.56 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 4.39 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 3.71 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 3.46 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 5.47 Bn |
| 10 | Vertex Pharmaceuticals | 136.55 Bn | 104.28 Bn | 2.91 Bn | 712.90 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 27, 2026 | 6.18 Bn |
| Jun 28, 2026 | 7.14 Bn |
| Mar 29, 2026 | 6.36 Bn |
| Dec 28, 2025 | 5.51 Bn |
| Sep 28, 2025 | 7.03 Bn |
| Jun 29, 2025 | 6.65 Bn |
| Mar 30, 2025 | 6.18 Bn |
| Dec 29, 2024 | 3.60 Bn |
| Sep 29, 2024 | 5.04 Bn |
| Jun 30, 2024 | 6.47 Bn |
| Mar 31, 2024 | 5.91 Bn |
| Dec 31, 2023 | 4.25 Bn |
| Oct 1, 2023 | 5.74 Bn |
| Jul 2, 2023 | 5.81 Bn |
| Apr 2, 2023 | 5.72 Bn |
| Dec 31, 2022 | 20.74 Bn |
| Oct 2, 2022 | 5.30 Bn |
| Jul 3, 2022 | 3.88 Bn |
| Apr 3, 2022 | 4.35 Bn |
| Dec 31, 2021 | 20.73 Bn |
Johnson & Johnson Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=JNJ&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "JNJ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=JNJ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();